Cerevel Therapeutics Holdings, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2020 to Q1 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2020 to Q1 2024.
  • Cerevel Therapeutics Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 31, 2024 was 182M shares, a 16% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 182M +25.1M +16% Mar 31, 2024 10-K/A 2024-04-26
Q3 2023 180M +24M +15.3% Oct 27, 2023 10-Q 2023-11-01
Q2 2023 157M +8.99M +6.05% Jul 28, 2023 10-Q 2023-08-02
Q1 2023 157M +8.54M +5.76% Apr 28, 2023 10-Q 2023-05-03
Q4 2022 157M Feb 10, 2023 10-K/A 2023-05-19
Q3 2022 156M +9.09M +6.17% Oct 28, 2022 10-Q 2022-11-08
Q2 2022 149M +3.63M +2.51% Jul 25, 2022 10-Q 2022-08-01
Q1 2022 148M +21M +16.5% May 2, 2022 10-Q 2022-05-10
Q3 2021 147M Nov 5, 2021 10-Q 2021-11-10
Q2 2021 145M Aug 6, 2021 10-Q 2021-08-11
Q1 2021 127M Mar 15, 2021 10-K 2021-03-24
Q4 2020 127M Nov 16, 2020 10-Q 2020-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.